Physician profile
Kenneth R Stringer
NPI 1225013592
$1,190.14
in general payments reported to CMS, 2019-2025
18 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $250 · 2021: $77.97 · 2023: $15.14 · 2024: $58.78 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $409.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $276.55 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $269.89 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals Lp | $163.56 | 2019-2020 | |
| Glaxosmithkline, LLC. | $92.22 | 2020-2025 | Arexvy, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $78.99 | 2019-2025 | Xifaxan |
| Pfizer INC. | $73.74 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.34 | 2020-2025 | Jardiance |
| Sanofi Pasteur INC. | $28.62 | 2019 | |
| Kyowa Kirin, INC. | $26.93 | 2025 | |
| Exact Sciences Corporation | $23.78 | 2025 | The Cologuard Plus Collection Kit |
| Sumitomo Pharma America, INC. | $15.14 | 2023 | Gemtesa |
| Electromed, INC. | $14.18 | 2025 | Smartvest |
| Abbott Laboratories | $13.25 | 2020 | |
| Allergan, INC. | $12.82 | 2020 | |
| Abbvie INC. | $12.52 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $11.79 | 2019 | |
| Phathom Pharmaceuticals, INC. | $11.47 | 2025 | Voquezna |
| Amgen INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Stringer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.